Bioline Rx reported $13.67M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Arca Biopharma USD 20.97M 8.86M Sep/2025
Bio Path USD 7.86M 3.12M Jun/2025
Bioline Rx USD 13.67M 1.81M Sep/2025
Capricor Therapeutics USD 28.15M 249K Sep/2025